RS52818B - Farmaceutska formulacija sa kontrolisanim otpuštanjem koja sadrži natrijum alginat i natrijum kalcijum alginat - Google Patents

Farmaceutska formulacija sa kontrolisanim otpuštanjem koja sadrži natrijum alginat i natrijum kalcijum alginat

Info

Publication number
RS52818B
RS52818B YU20050276A YUP27605A RS52818B RS 52818 B RS52818 B RS 52818B YU 20050276 A YU20050276 A YU 20050276A YU P27605 A YUP27605 A YU P27605A RS 52818 B RS52818 B RS 52818B
Authority
RS
Serbia
Prior art keywords
alginate
sodium
controlled release
release pharmaceutical
pharmaceutical compositions
Prior art date
Application number
YU20050276A
Other languages
English (en)
Inventor
Robert Pisek
Andrejka Kramar
Franc Vrecer
Maja Kincl
Marjanca Breznik
Original Assignee
Krka Tovarna Zdravil D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka Tovarna Zdravil D.D. filed Critical Krka Tovarna Zdravil D.D.
Publication of RS20050276A publication Critical patent/RS20050276A/sr
Publication of RS52818B publication Critical patent/RS52818B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Farmaceutska formulacija sa kontrolisanim oslobadjanjem, koja sadrži: (a) najmanje jedan aktivan sastojak, (b) natrijum alginat, i (c) natrijum-kalcijum alginat naznačena time, da je težinski odnos natrijum alginata (b) prema natrijum-kalcijum alginatu (c) od 1:1,1 do 1:2.Prijava sadrži još 1 nezavisni i 9 zavisnih patentnih zahteva.
YU20050276A 2002-10-08 2003-10-06 Farmaceutska formulacija sa kontrolisanim otpuštanjem koja sadrži natrijum alginat i natrijum kalcijum alginat RS52818B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI200200242A SI21300A (sl) 2002-10-08 2002-10-08 Farmacevtske formulacije z alginati
PCT/SI2003/000034 WO2004032904A1 (en) 2002-10-08 2003-10-06 Controlled release pharmaceutical compositions containing sodium alginate and sodium calcium alginate

Publications (2)

Publication Number Publication Date
RS20050276A RS20050276A (en) 2007-06-04
RS52818B true RS52818B (sr) 2013-10-31

Family

ID=32091983

Family Applications (1)

Application Number Title Priority Date Filing Date
YU20050276A RS52818B (sr) 2002-10-08 2003-10-06 Farmaceutska formulacija sa kontrolisanim otpuštanjem koja sadrži natrijum alginat i natrijum kalcijum alginat

Country Status (9)

Country Link
EP (1) EP1560568B1 (sr)
AU (1) AU2003273212A1 (sr)
EA (1) EA007488B1 (sr)
HR (1) HRP20050312B1 (sr)
PL (1) PL208591B1 (sr)
RS (1) RS52818B (sr)
SI (2) SI21300A (sr)
UA (1) UA80990C2 (sr)
WO (1) WO2004032904A1 (sr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0515973B8 (pt) 2004-10-12 2021-07-27 Fmc Biopolymer As kit para produzir um gel de alginato, composição para preparar um gel e uso
AU2008296975B2 (en) 2007-08-28 2014-07-24 Fmc Corporation Delayed self-gelling alginate systems and uses thereof
CN108853039B (zh) * 2018-08-07 2021-03-09 河北君临药业有限公司 一种克拉霉素分散片及其生产工艺

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3583799D1 (de) * 1985-01-11 1991-09-19 Abbott Lab Ltd Feste zubereitung mit langsamer freisetzung.
EP0275336A1 (de) * 1987-01-20 1988-07-27 Knoll Ag Arzneimittelzubereitung mit protahierender Wirkung
US5705190A (en) * 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
SI20108B (en) * 1997-06-11 2001-12-31 Abbott Lab A controlled release formulation for poorly soluble basic drugs

Also Published As

Publication number Publication date
SI1560568T1 (sl) 2014-08-29
SI21300A (sl) 2004-04-30
EA007488B1 (ru) 2006-10-27
WO2004032904A1 (en) 2004-04-22
PL208591B1 (pl) 2011-05-31
UA80990C2 (en) 2007-11-26
HRP20050312A2 (en) 2006-02-28
EP1560568A1 (en) 2005-08-10
HRP20050312B1 (hr) 2014-09-26
EA200500613A1 (ru) 2005-10-27
PL374487A1 (en) 2005-10-31
AU2003273212A1 (en) 2004-05-04
RS20050276A (en) 2007-06-04
EP1560568B1 (en) 2014-03-26

Similar Documents

Publication Publication Date Title
RS51746B (sr) Atorvastatin kalcijum u farmaceutskom obliku, njegovoj smeši i farmaceutskoj formulaciji, koja sadrži atorvastatin kalcijum
AU2003274681A1 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
HRP20040996B1 (en) High drug load tablet
ATE302616T1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
EA200600598A1 (ru) Лекарственные формы замедленного высвобождения
TW200505406A (en) Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
DE69942154D1 (de) Medikamenthaltige zusammensetzung in aerosolform
BR0003158A (pt) Formulação de dosagem oral de derretimentoinstantâneo
DE69940557D1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
HUP0401911A2 (hu) Kártevőirtó készítmények és alkalmazásuk
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
ES2130081B1 (es) Comprimido de maleato de trimebutina con recubrimiento laminar.
WO2005065639A3 (en) Novel pharmaceutical compositions
AR018607A1 (es) Preparacion farmaceutica que en calidad de ingrediente activo contiene levotiroxina sodica, y un procedimiento para su preparacion
RS52818B (sr) Farmaceutska formulacija sa kontrolisanim otpuštanjem koja sadrži natrijum alginat i natrijum kalcijum alginat
ATE412404T1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
DK1546067T3 (da) Rygesammensætning
HRPK20030766B3 (en) Combination of a taxane and cyclin-dependent kinase inhibitor
BR0001144B1 (pt) Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase
WO2005037247A3 (en) Oral matrix formulations of doxazosin
HRPK20040924B3 (en) Preparation based on curcumae longae rhizomae roots
RU2003114406A (ru) Витаминная композиция
DE50311479D1 (de) Pharmazeutische zusammensetzung, enthaltend oxcarbazepin mit kontrollierter wirkstofffreisetzung
RS50256B (sr) Farmaceutska kompozicija za lečenje mioma materice
UY26605A1 (es) Sistema de administración oral controlada para la ingestión diaria de ciprofloxacina